A detailed history of Hantz Financial Services, Inc. transactions in Grifols Sa stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 195,815 shares of GRFS stock, worth $1.61 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
195,815
Holding current value
$1.61 Million
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$6.27 - $7.7 $1.23 Million - $1.51 Million
195,815 New
195,815 $1.24 Million
Q1 2024

Aug 06, 2024

SELL
$5.47 - $11.38 $11,481 - $23,886
-2,099 Reduced 1.19%
173,648 $1.16 Million
Q4 2023

Aug 06, 2024

SELL
$7.71 - $11.56 $41,957 - $62,909
-5,442 Reduced 3.0%
175,747 $2.03 Million
Q3 2023

Aug 06, 2024

BUY
$8.91 - $10.91 $25,438 - $31,148
2,855 Added 1.6%
181,189 $1.66 Million
Q2 2023

Aug 06, 2024

BUY
$7.14 - $9.29 $14,401 - $18,737
2,017 Added 1.14%
178,334 $1.63 Million
Q1 2023

Aug 06, 2024

BUY
$6.65 - $10.69 $43,537 - $69,987
6,547 Added 3.86%
176,317 $1.3 Million
Q4 2022

Aug 06, 2024

BUY
$5.96 - $8.53 $1,972 - $2,823
331 Added 0.2%
169,770 $1.44 Million
Q3 2022

Aug 06, 2024

BUY
$5.95 - $14.3 $11,400 - $27,398
1,916 Added 1.14%
169,439 $1.04 Million
Q2 2022

Aug 06, 2024

BUY
$10.6 - $13.28 $104,378 - $130,768
9,847 Added 6.25%
167,523 $1.99 Million
Q1 2022

Aug 06, 2024

BUY
$10.37 - $12.73 $153,797 - $188,798
14,831 Added 10.38%
157,676 $1.84 Million
Q4 2021

Aug 06, 2024

BUY
$10.21 - $15.27 $350,090 - $523,593
34,289 Added 31.59%
142,845 $1.6 Million
Q3 2021

Aug 06, 2024

BUY
$14.07 - $17.3 $471,992 - $580,345
33,546 Added 44.72%
108,556 $1.59 Million
Q2 2021

Aug 06, 2024

BUY
$16.62 - $18.94 $360,221 - $410,505
21,674 Added 40.64%
75,010 $1.3 Million
Q1 2021

Aug 06, 2024

SELL
$15.15 - $19.78 $2.16 Million - $2.82 Million
-142,479 Reduced 72.76%
53,336 $922,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.